BRPI1007443A2 - biomarcadores séricos e de urina associados à nefropatia diabética - Google Patents
biomarcadores séricos e de urina associados à nefropatia diabéticaInfo
- Publication number
- BRPI1007443A2 BRPI1007443A2 BRPI1007443A BRPI1007443A BRPI1007443A2 BR PI1007443 A2 BRPI1007443 A2 BR PI1007443A2 BR PI1007443 A BRPI1007443 A BR PI1007443A BR PI1007443 A BRPI1007443 A BR PI1007443A BR PI1007443 A2 BRPI1007443 A2 BR PI1007443A2
- Authority
- BR
- Brazil
- Prior art keywords
- serum
- diabetic nephropathy
- biomarkers associated
- urine biomarkers
- urine
- Prior art date
Links
- 208000007342 Diabetic Nephropathies Diseases 0.000 title 1
- 239000000090 biomarker Substances 0.000 title 1
- 208000033679 diabetic kidney disease Diseases 0.000 title 1
- 210000002966 serum Anatomy 0.000 title 1
- 210000002700 urine Anatomy 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4728—Details alpha-Glycoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
- G01N2333/8121—Serpins
- G01N2333/8125—Alpha-1-antitrypsin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14777809P | 2009-01-28 | 2009-01-28 | |
| US61/147,778 | 2009-01-28 | ||
| PCT/CA2010/000097 WO2010085879A1 (en) | 2009-01-28 | 2010-01-27 | Urine and serum biomarkers associated with diabetic nephropathy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI1007443A2 true BRPI1007443A2 (pt) | 2017-09-12 |
| BRPI1007443B1 BRPI1007443B1 (pt) | 2020-10-13 |
| BRPI1007443B8 BRPI1007443B8 (pt) | 2021-07-27 |
Family
ID=42395076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1007443A BRPI1007443B8 (pt) | 2009-01-28 | 2010-01-27 | método para diagnosticar nefropatia diabética em um indivíduo, método para avaliar a eficácia de um tratamento para nefropatia diabética em um indivíduo, método para determinação do estágio da nefropatia diabética em um indivíduo, método para monitoramento do progresso da nefropatia diabética em um indivíduo, e método para avaliar a eficácia de um tratamento para nefropatia diabética em um indivíduo |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US8465980B2 (pt) |
| EP (2) | EP2623517B8 (pt) |
| JP (1) | JP5689426B2 (pt) |
| CN (1) | CN102300877B (pt) |
| BR (1) | BRPI1007443B8 (pt) |
| CA (1) | CA2748937C (pt) |
| DK (2) | DK2391654T3 (pt) |
| ES (2) | ES2552557T3 (pt) |
| HU (2) | HUE025795T2 (pt) |
| MX (1) | MX2011007811A (pt) |
| PL (2) | PL2391654T3 (pt) |
| PT (2) | PT2391654E (pt) |
| TW (1) | TWI449910B (pt) |
| WO (1) | WO2010085879A1 (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2391653E (pt) * | 2009-01-28 | 2015-02-13 | Ind Tech Res Inst | Biomarcadores associados a nefropatia |
| CN103299192B (zh) * | 2010-09-21 | 2016-05-11 | 普罗蒂阿米克斯国际有限公司 | 与糖尿病前期、糖尿病以及糖尿病相关病症相关的生物标记 |
| JP5714285B2 (ja) * | 2010-09-29 | 2015-05-07 | 株式会社プロトセラ | 妊娠高血圧症候群マーカーおよびそれを用いた診断 |
| EP2592421B1 (en) * | 2011-11-14 | 2017-08-30 | Universitätsklinikum Jena | Diagnosis of sepsis and systemic inflammatory response syndrome |
| JP2013178239A (ja) * | 2012-01-31 | 2013-09-09 | Ajinomoto Co Inc | 早期腎症の評価方法、早期腎症評価装置、早期腎症評価方法、早期腎症評価プログラム、早期腎症評価システムおよび情報通信端末装置 |
| WO2013122976A1 (en) * | 2012-02-13 | 2013-08-22 | New York University | Osteopontin isoform a inhibitors and methods of use |
| GB201203938D0 (en) * | 2012-03-06 | 2012-04-18 | Binding Site Group The Ltd | Assay system |
| CA2818328C (en) | 2012-06-11 | 2017-09-05 | Preventage Healthcare Llc | Methods for improving diabetes management |
| EP3066476A2 (en) * | 2013-11-04 | 2016-09-14 | The Regents of the University of Michigan | Biomarkers and methods for progression prediction for chronic kidney disease |
| CN103804484B (zh) * | 2014-01-24 | 2016-03-16 | 南京必优康生物技术有限公司 | 一种网红细胞生长因子及其制备方法和应用 |
| CN105572355B (zh) * | 2015-03-13 | 2018-04-13 | 中国医学科学院肿瘤医院 | 检测食管癌的生物标志物 |
| US11216742B2 (en) | 2019-03-04 | 2022-01-04 | Iocurrents, Inc. | Data compression and communication using machine learning |
| CN114487431A (zh) * | 2020-11-12 | 2022-05-13 | 首都医科大学附属北京世纪坛医院 | 尿液α-2-HS-糖蛋白及其多肽片段在妊娠糖尿病中的应用 |
| CN113687083B (zh) * | 2021-08-20 | 2023-11-28 | 天津中医药大学 | 一种基于深度学习的糖尿病肾病早期预测方法及系统 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999015904A1 (en) | 1997-09-26 | 1999-04-01 | University Of Washington | Methods and compositions for diagnosing renal pathologies |
| JP2002090365A (ja) * | 2000-02-08 | 2002-03-27 | Internatl Reagents Corp | 腎障害の検査手段 |
| DE60029302T2 (de) * | 2000-04-28 | 2007-08-09 | Bayer Ag | Diagnose von Leberfibrose mit Hilfe von Serummarkeralgorithmen |
| IL153206A0 (en) * | 2000-06-13 | 2003-07-06 | Childrens Medical Center | Biosynthetic oncolytic molecules and uses therefor |
| DK1345969T3 (da) * | 2000-12-26 | 2010-11-29 | Inst Nat Sante Rech Med | Anti-CD28-antistof |
| WO2003019193A1 (en) * | 2001-08-30 | 2003-03-06 | Ciphergen Biosystems, Inc. | Method of diagnosing nephrotic syndrome |
| US20040171081A1 (en) * | 2001-11-23 | 2004-09-02 | Abraham Mittelman | Antigens |
| WO2004082617A2 (en) * | 2003-03-14 | 2004-09-30 | Ppd Biomarker Discovery Sciences, Llc | Biological markers for diagnosing rheumatoid arthritis |
| US20060286602A1 (en) * | 2004-05-10 | 2006-12-21 | Harald Mischak | Method and markers for the diagnosis of renal diseases |
| US20050266467A1 (en) * | 2004-05-19 | 2005-12-01 | Ppd Biomarker Discovery Sciences, Llc | Biomarkers for multiple sclerosis and methods of use thereof |
| WO2006044666A2 (en) * | 2004-10-15 | 2006-04-27 | Northeastern University | Detection of disease associated proteolysis by direct mass spectrometry analysis of low molecular weight peptides |
| DK1806359T3 (da) * | 2005-09-05 | 2010-06-14 | Immatics Biotechnologies Gmbh | Tumorassocierede peptider, der bindes promiskuøst til Humant Leukocyt-Antigen (HLA) klasse II molekyler |
| EP1946121A2 (en) * | 2005-10-27 | 2008-07-23 | Yale University, Inc. | Urinary proteomic biomarker patterns in preeclampsia |
| US20070111245A1 (en) * | 2005-11-09 | 2007-05-17 | Ravi Thadhani | Predicting diabetic nephropathy |
| WO2007110230A2 (en) * | 2006-03-27 | 2007-10-04 | Institut Pasteur | Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections |
| JP5244103B2 (ja) * | 2006-08-09 | 2013-07-24 | ホームステッド クリニカル コーポレイション | 器官特異的蛋白質およびその使用方法 |
| WO2008092214A1 (en) | 2007-02-02 | 2008-08-07 | Minomic International Limited | Biomarkers for diabetes |
| EP2479565A3 (en) | 2007-03-26 | 2012-09-26 | Novartis AG | Predictive renal safety biomarkers and biomarker signatures to monitor kidney function |
| US20110214990A1 (en) * | 2008-09-17 | 2011-09-08 | Mosaiques Diagnostics And Therapeutics Ag | Kidney cell carcinoma |
| PT2391653E (pt) * | 2009-01-28 | 2015-02-13 | Ind Tech Res Inst | Biomarcadores associados a nefropatia |
-
2010
- 2010-01-27 BR BRPI1007443A patent/BRPI1007443B8/pt active IP Right Grant
- 2010-01-27 EP EP13162626.9A patent/EP2623517B8/en active Active
- 2010-01-27 US US12/694,575 patent/US8465980B2/en active Active
- 2010-01-27 EP EP10735454.0A patent/EP2391654B1/en active Active
- 2010-01-27 PT PT107354540T patent/PT2391654E/pt unknown
- 2010-01-27 HU HUE10735454A patent/HUE025795T2/en unknown
- 2010-01-27 DK DK10735454.0T patent/DK2391654T3/en active
- 2010-01-27 WO PCT/CA2010/000097 patent/WO2010085879A1/en not_active Ceased
- 2010-01-27 ES ES13162626.9T patent/ES2552557T3/es active Active
- 2010-01-27 MX MX2011007811A patent/MX2011007811A/es active IP Right Grant
- 2010-01-27 PL PL10735454T patent/PL2391654T3/pl unknown
- 2010-01-27 CN CN201080005751.2A patent/CN102300877B/zh active Active
- 2010-01-27 JP JP2011546555A patent/JP5689426B2/ja active Active
- 2010-01-27 HU HUE13162626A patent/HUE025796T2/hu unknown
- 2010-01-27 CA CA2748937A patent/CA2748937C/en active Active
- 2010-01-27 PT PT131626269T patent/PT2623517E/pt unknown
- 2010-01-27 DK DK13162626.9T patent/DK2623517T3/en active
- 2010-01-27 ES ES10735454.0T patent/ES2552467T3/es active Active
- 2010-01-27 PL PL13162626T patent/PL2623517T3/pl unknown
- 2010-01-28 TW TW099102367A patent/TWI449910B/zh active
- 2010-12-15 US US12/969,039 patent/US8476077B2/en active Active
- 2010-12-20 US US12/972,936 patent/US20110086371A1/en not_active Abandoned
-
2013
- 2013-05-24 US US13/901,819 patent/US10101340B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1007443A2 (pt) | biomarcadores séricos e de urina associados à nefropatia diabética | |
| BRPI0820557A2 (pt) | biomarcadores diagnósticos de diabetes | |
| IL233096A0 (en) | Ratio based biomarkers and methods of use thereof | |
| EP2443259A4 (en) | BIOMARKERS ASSOCIATED WITH AUTISM AND USES THEREOF | |
| FI20096188A0 (fi) | Nutrigeneettisiä biomarkkereita lihavuudelle ja tyypin 2 diabetekselle | |
| EP2370658A4 (en) | DRILLING TIP WITH TROCAR TIP | |
| BRPI1009269A2 (pt) | biomarcadores de envelhecimento específicos do tecido. | |
| BRPI0909948A2 (pt) | alteração de células duplas em serviço otimizadas. | |
| EP2438196A4 (en) | REAGENTS AND RECOMBINASE POLYMERASE AMPLIFICATION KITS | |
| EP2451600A4 (en) | ARRANGEMENT OF A DOUBLE-SIDED INDEXABLE CUTTING INSERT AND A REINFORCEMENT ELEMENT | |
| BRPI0920069A2 (pt) | biomarcadores | |
| WO2010036342A9 (en) | Urinary biomarkers for predicting long-term dialysis | |
| EP2089722A4 (en) | BIOMARKERS | |
| EP2265642A4 (en) | BIOMARKERS | |
| BRPI1006075A2 (pt) | biomarcadores de cancer | |
| BR112012008080A2 (pt) | ensaios de rastreamento in vivo. | |
| GB2474618B (en) | Predictive biomarkers | |
| EP2129285A4 (en) | Analyte sensor | |
| BR112012013418A2 (pt) | marcador sérico bioquímico. | |
| BRPI0820721A2 (pt) | Reagentes e métodos para detectar analitos | |
| BR112012008045A8 (pt) | dispositivo de mancal intermediário com reforço de endentação para arranques | |
| FI20095300A0 (fi) | Kärkiosapipetti | |
| EP2263086A4 (en) | BIOMARKERS | |
| FI20080247L (fi) | Nupillinen pipetti | |
| EP2265641A4 (en) | BIOMARKERS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B25A | Requested transfer of rights approved |
Owner name: BIO PREVENTIVE MEDICINE CORPORATION (TW) |
|
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
| B06A | Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/10/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/01/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO |